Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.65 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.45 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.45 |
| ▸ | MDM4 | O15151 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CASP3 | P42574 | 2/20 | 0.43 |
| ▸ | TLR2 | O60603 | 1/20 | 0.42 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.42 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17746951 | 1.00 | KMT2A (0.65) | KMT2AEPHX2SLC1A3SLC1A1MDM4 | |
| SCHEMBL17746952 | 1.00 | KMT2A (0.65) | KMT2AEPHX2SLC1A3SLC1A1MDM4 | |
| SCHEMBL29401369 | 0.96 | KMT2A (0.67) | KMT2AEPHX2SLC1A3SLC1A1MDM4 | |
| SCHEMBL29401202 | 0.96 | KMT2A (0.67) | KMT2AEPHX2SLC1A3SLC1A1MDM4 | |
| SCHEMBL13160289 | 0.96 | KMT2A (0.67) | KMT2AEPHX2SLC1A3SLC1A1MDM4 | |
| SCHEMBL10052316 | 0.96 | KMT2A (0.67) | KMT2AEPHX2SLC1A3SLC1A1MDM4 | |
| SCHEMBL29679073 | 0.96 | KMT2A (0.67) | KMT2AEPHX2SLC1A3SLC1A1MDM4 | |
| SCHEMBL29398504 | 0.96 | KMT2A (0.67) | KMT2AEPHX2SLC1A3SLC1A1MDM4 | |
| SCHEMBL2089280 | 0.96 | KMT2A (0.67) | KMT2AEPHX2SLC1A3SLC1A1MDM4 | |
| SCHEMBL31453877 | 0.95 | KMT2A (0.66) | KMT2AEPHX2SLC1A3SLC1A1MDM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4622966-A1 | NEUROPEPTIDE Y1 RECEPTOR (NPY1R) TARGETED THERAPEUTICS AND USES THEREOF | Radionetics Oncology, Inc. (US) | 2025-10-01 | — | — | EP | disclosed |
| WO-2024112612-A1 | NEUROPEPTIDE Y1 RECEPTOR (NPY1R) TARGETED THERAPEUTICS AND USES THEREOF | RADIONETICS ONCOLOGY, INC. (US) | 2024-05-30 | — | — | WO | disclosed |